Drug intelligence / Profile preview

ethacridine

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Extra-amniotic, Intra-amniotic
01

Overview

Ethacridine is an acridine derivative primarily used as a topical antiseptic and as an abortifacient agent. As an antiseptic, it is effective mainly against Gram-positive bacteria such as Streptococci and Staphylococci, but less so against Gram-negative bacteria. It is commonly applied in 0.1% solutions for the treatment of purulent skin infections, infected mucous membranes, wounds (including those that are difficult to heal), genital inflammation, oral infections, and skin abrasions[1][8]. Ethacridine's mechanism of action involves binding to bacterial DNA and inhibiting microbial protein synthesis by preventing DNA and RNA synthesis within the cell[8]. In obstetrics, it has been used for second-trimester abortion via extra-amniotic or intra-amniotic instillation; this method is considered safer than hypertonic saline[1][5]. Recent research also suggests that ethacridine can inactivate viral particles such as SARS-CoV-2 by preventing their binding to host cells[6].

Brand names
RivanolAcrinol
Other names
ethacridine lactate2-ethoxy-6,9-diaminoacridine monolactate monohydrate
02

Targets

Neuraminidase

Beyond the preview

Go deeper on ethacridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethacridine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call